Seeing Is Believing
Currently out of the existing stock ratings of Jayson Bedford, 249 are a BUY (96.51%), 8 are a HOLD (3.1%), 1 are a SELL (0.39%).
Analyst Jayson Bedford, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 59.08% that have a potential upside of 19.16% achieved within 238 days.
Jayson Bedford’s has documented 513 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABT, Abbott Laboratories at 15-Oct-2025.
Analyst best performing recommendations are on SENS (SENSEONICS HOLDINGS).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 2/5/2020. The price target of $85 was fulfilled within 9 days with a profit of $10.69 (14.39%) receiving and performance score of 15.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$162
$33.46 (26.03%)
$159
4 days ago
(16-Oct-2025)
18/25 (72%)
$33.46 (26.03%)
499
Buy
$142
$13.46 (10.47%)
$144
5 days ago
(15-Oct-2025)
7/11 (63.64%)
$14.37 (11.26%)
317
Buy
$146
$17.46 (13.58%)
$141
5 days ago
(15-Oct-2025)
18/23 (78.26%)
$18.37 (14.39%)
376
Buy
$145
$16.46 (12.81%)
$137
3 months 3 days ago
(17-Jul-2025)
13/14 (92.86%)
$21.33 (17.25%)
369
Buy
$145
$16.46 (12.81%)
$139
3 months 3 days ago
(17-Jul-2025)
6/9 (66.67%)
$21.33 (17.25%)
753
Which stock is Jayson Bedford is most bullish on?
Which stock is Jayson Bedford is most reserved on?
What Year was the first public recommendation made by Jayson Bedford?